| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 37.941 | 34.944 | 32.322 | 35.118 | 33.856 | 32.755 | 32.077 | 34.084 | - | - |
| Total Income - EUR | 37.941 | 34.944 | 32.322 | 35.118 | 33.856 | 32.755 | 32.077 | 34.084 | - | - |
| Total Expenses - EUR | 38.264 | 37.719 | 31.354 | 42.186 | 33.775 | 33.316 | 33.457 | 35.639 | - | - |
| Gross Profit/Loss - EUR | -323 | -2.775 | 968 | -7.068 | 81 | -561 | -1.381 | -1.556 | - | - |
| Net Profit/Loss - EUR | -1.461 | -3.474 | 636 | -7.419 | -258 | -889 | -1.702 | -1.897 | - | - |
| Employees | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | - | - |
Check the financial reports for the company - Biomarket Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.829 | 13.349 | 13.123 | 5.757 | 5.427 | 5.110 | 5.469 | 5.276 | - | - |
| Current Assets | 2.921 | 1.012 | 1.017 | 1.137 | 2.054 | 1.682 | 1.654 | 880 | - | - |
| Inventories | 2.546 | 813 | 777 | 777 | 1.815 | 1.393 | 1.423 | 570 | - | - |
| Receivables | 9 | 0 | 3 | 74 | 65 | 20 | 33 | 101 | - | - |
| Cash | 367 | 199 | 238 | 285 | 174 | 269 | 198 | 209 | - | - |
| Shareholders Funds | 4.220 | 703 | 1.328 | -6.408 | -6.541 | -7.308 | -8.848 | -10.772 | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | 12.530 | 13.657 | 12.813 | 13.302 | 14.022 | 14.099 | 15.971 | 16.928 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Biomarket Srl